AURA Biosciences (NASDAQ: AURA) net income
AURA Biosciences reported a net loss of $106.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $86.9m. Earnings per share were −$1.76.
AURA Biosciences's best year of the last 6 was fiscal 2020. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$106.2m | — | — | −$1.76 |
| 2024 | −$86.9m | — | — | −$1.75 |
| 2023 | −$76.4m | — | — | −$1.93 |
| 2022 | −$58.8m | — | — | −$1.96 |
| 2021 | −$35.3m | — | — | −$8.95 |
| 2020 | −$22.2m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
AURA Biosciences net income compared with its sector
By net income for its latest fiscal year, AURA Biosciences ranks 343rd of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 341st | Capricor Therapeutics | −$105.0m | — |
| 342nd | Oruka Therapeutics | −$105.4m | — |
| 343rd | AURA Biosciences | −$106.2m | — |
| 344th | Quanterix | −$107.2m | −77.1% |
| 345th | NeoGenomics | −$108.0m | −14.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of AURA Biosciences
- How much did AURA Biosciences earn in fiscal 2025?
- AURA Biosciences reported a net loss of $106.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $86.9m.
- What are the earnings per share of AURA Biosciences?
- They were −$1.76 in fiscal 2025, compared with −$1.75 in fiscal 2024.
- Where does AURA Biosciences rank in its sector by net income?
- It ranks 343rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for AURA Biosciences come from?
- From the annual report (Form 10-K) that AURA Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that AURA Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on AURA Biosciences: the AURA Biosciences page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.